Abbott has unveiled its next generation point of care diagnostics offering, launching it under the new brand name of Alinity. The suite of products comprises next generation immunoassay ...

Abbott has been investing in their point-of-care diagnostics, which has seen strong revenue growth recently. Considering both the core lab and point-of-care market, I predict their revenue will ...

and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Market Capitalization Analysis: The company's market capitalization is ...